LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

Search

Medtronic PLC

Chiusa

SettoreSettore sanitario

92.93 0.03

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

91.76

Massimo

92.96

Metriche Chiave

By Trading Economics

Entrata

-17M

1B

Vendite

-349M

8.6B

P/E

Media del settore

25.638

35.733

EPS

1.26

Rendimento da dividendi

3.06

Margine di Profitto

12.124

Dipendenti

95,000

EBITDA

-50M

2.2B

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+7.1% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

3.06%

3.13%

Utili prossimi

18 nov 2025

Prossima data del Dividendo

17 ott 2025

Prossima data del' Ex Dividendo

26 set 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

133M

119B

Apertura precedente

92.9

Chiusura precedente

92.93

Notizie sul Sentiment di mercato

By Acuity

26%

74%

82 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bearish Evidence

Medtronic PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

19 ago 2025, 11:39 UTC

Utili

Medtronic Posts Higher 1Q Revenue, Boosts Outlook as Tariffs Ease

21 mag 2025, 11:38 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Medtronic Boosts Dividend, Plans to Separate Diabetes Business and Targets Revenue Growth for Year

19 ago 2025, 20:33 UTC

Utili
Acquisizioni, Fusioni, Takeovers

These Stocks Moved the Most Today: Intel, Home Depot, Palo Alto, Viking Therapeutics, Palantir, Medtronic, and More -- Barrons.com

19 ago 2025, 17:41 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19 ago 2025, 13:35 UTC

Azioni calde

Stocks to Watch Tuesday: Intel, Medtronic, Home Depot -- WSJ

19 ago 2025, 12:48 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19 ago 2025, 11:27 UTC

Utili

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19 ago 2025, 10:51 UTC

Utili

Medtronic Sees FY26 Reported Revenue Growth 6.5%-6.8% >MDT

19 ago 2025, 10:50 UTC

Utili

Medtronic Had Seen FY26 Adjusted EPS $5.50-$5.60 >MDT

19 ago 2025, 10:50 UTC

Utili

Medtronic Raises FY26 View To Adj EPS $5.60-Adj EPS $5.66 >MDT

19 ago 2025, 10:50 UTC

Utili

Medtronic Cuts FY26 Potential Tariff Impact View to About $185M From $200M-$350M >MDT

19 ago 2025, 10:49 UTC

Utili

Medtronic Raises FY26 Adjusted EPS Growth View to About 4.5% From About 4%, Excluding Potential Tariff Impact >MDT

19 ago 2025, 10:48 UTC

Utili

Medtronic Still Sees FY26 Organic Revenue Up About 5% >MDT

19 ago 2025, 10:45 UTC

Utili

Medtronic 1Q Medical Surgical Portfolio Rev $2.08B >MDT

19 ago 2025, 10:45 UTC

Utili

Medtronic 1Q Cardiovascular Portfolio Rev $3.29B >MDT

19 ago 2025, 10:45 UTC

Utili

Medtronic 1Q Neuroscience Portfolio Rev $2.42B >MDT

19 ago 2025, 10:45 UTC

Utili

Medtronic 1Q Organic Revenue Up 4.8% >MDT

19 ago 2025, 10:45 UTC

Utili

Medtronic 1Q EPS 81c >MDT

19 ago 2025, 10:45 UTC

Utili

Medtronic 1Q Net $1.04B >MDT

19 ago 2025, 10:45 UTC

Utili

Medtronic 1Q Diabetes Rev $721M >MDT

19 ago 2025, 10:45 UTC

Utili

Medtronic 1Q Sales $8.58B >MDT

19 ago 2025, 10:45 UTC

Utili

Medtronic 1Q Adj EPS $1.26 >MDT

19 ago 2025, 09:12 UTC

Azioni calde

Stocks to Watch Tuesday: Intel, Palo Alto, Tegna, Home Depot -- WSJ

12 giu 2025, 13:01 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic Targeting Completion of Planned Separation Within 18 Mos of Initial Announcement >MDT

21 mag 2025, 17:23 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

Medtronic to Separate Diabetes Business as Stand-Alone Company -- 2nd Update

21 mag 2025, 11:39 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

Medtronic to Separate Diabetes Business as Stand-Alone Company -- Update

21 mag 2025, 10:52 UTC

Utili

Medtronic Sees FY26 Adjusted EPS Up About 4% Excluding Potential Impacts From Increased Tariffs >MDT

21 mag 2025, 10:51 UTC

Utili

Medtronic Sees FY26 Adj EPS $5.50-Adj EPS $5.60, Including Potential Tariff Impact >MDT

21 mag 2025, 10:50 UTC

Utili

Medtronic Sees FY26 Reported Revenue Up 4.8%-5.1% if Recent Forex Rates Hold >MDT

21 mag 2025, 10:49 UTC

Utili

Medtronic Sees FY26 Organic Revenue Growth Up About 5% >MDT

Confronto tra pari

Modifica del prezzo

Medtronic PLC Previsione

Obiettivo di Prezzo

By TipRanks

7.1% in crescita

Previsioni per 12 mesi

Media 99.5 USD  7.1%

Alto 115 USD

Basso 78 USD

Basato su 25 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Medtronic PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

25 ratings

12

Acquista

12

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

83.26 / 84.875Supporto e resistenza

A breve termine

Weak Bearish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

82 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
help-icon Live chat